$2.4 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 91 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | BIOGEN INC | $196,893,000 | -6.4% | 487,432 | -2.2% | 8.21% | +2.8% |
| GILD | Sell | GILEAD SCIENCES INC | $152,720,000 | +17.9% | 1,304,407 | -1.2% | 6.37% | +29.5% |
| CELG | Buy | CELGENE CORP | $145,543,000 | +4.4% | 1,257,558 | +4.0% | 6.07% | +14.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $132,113,000 | -24.8% | 965,877 | -31.5% | 5.51% | -17.4% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $118,861,000 | +73.1% | 657,525 | +65.9% | 4.96% | +90.1% |
| INCY | Sell | INCYTE CORPORATION | $94,843,000 | -22.6% | 910,114 | -31.9% | 3.96% | -14.9% |
| REGN | New | REGENERON PHARMACEUTICALS | $89,222,000 | – | 174,900 | +100.0% | 3.72% | – |
| AMGN | Sell | AMGEN INC | $86,969,000 | -18.0% | 566,497 | -14.6% | 3.63% | -10.0% |
| HALO | Sell | HALOZYME THERAPEUTIC | $78,512,000 | +47.5% | 3,477,051 | -6.7% | 3.28% | +62.0% |
| TMO | Buy | THERMO FISHER SCIENTIFIC | $76,563,000 | -2.9% | 590,036 | +0.5% | 3.19% | +6.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS | $73,940,000 | +23.0% | 598,800 | +17.5% | 3.08% | +35.1% |
| FOLD | Buy | AMICUS THERAPEUTICS | $70,811,000 | +30.5% | 5,004,322 | +0.4% | 2.95% | +43.4% |
| PFE | Buy | PFIZER INC | $61,311,000 | +18.1% | 1,828,538 | +22.6% | 2.56% | +29.7% |
| SGEN | Buy | SEATTLE GENETICS INC | $61,084,000 | +37.1% | 1,262,075 | +0.1% | 2.55% | +50.6% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $53,254,000 | +20.7% | 1,169,130 | +0.6% | 2.22% | +32.5% |
| AGN | New | ALLERGAN PLCshares | $48,866,000 | – | 161,031 | +100.0% | 2.04% | – |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS | $42,880,000 | -7.8% | 177,647 | +7.7% | 1.79% | +1.3% |
| TTPH | Buy | TETRAPHASE PHARMACEUTICALS | $42,368,000 | +91.0% | 893,076 | +47.5% | 1.77% | +109.9% |
| MDT | Buy | MEDTRONIC PLCshares | $38,519,000 | +21.0% | 519,829 | +27.4% | 1.61% | +32.9% |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS | $36,165,000 | +16.8% | 682,736 | -36.3% | 1.51% | +28.3% |
| MRK | New | MERCK & CO INC | $34,946,000 | – | 613,842 | +100.0% | 1.46% | – |
| DXCM | Sell | DEXCOM INC | $31,845,000 | +27.9% | 398,158 | -0.4% | 1.33% | +40.4% |
| OMED | Sell | ONCOMED PHARMACEUTICALS | $30,815,000 | -22.1% | 1,369,534 | -10.7% | 1.28% | -14.4% |
| UTHR | Buy | UNITED THERAPEUTICS | $30,577,000 | +1.3% | 175,780 | +0.4% | 1.28% | +11.3% |
| ALGN | Buy | ALIGN TECH INC | $29,695,000 | +27.5% | 473,522 | +9.3% | 1.24% | +40.0% |
| PTCT | Sell | PTC THERAPEUTICS INC | $29,588,000 | -35.4% | 614,742 | -18.4% | 1.23% | -29.1% |
| RLYP | Buy | RELYPSA INC | $27,863,000 | -7.8% | 842,030 | +0.5% | 1.16% | +1.2% |
| SHPG | Sell | SHIRE PLCsp adr | $27,484,000 | -53.8% | 113,812 | -54.3% | 1.15% | -49.3% |
| ABT | Buy | ABBOTT LABS | $26,588,000 | +18.5% | 541,734 | +11.8% | 1.11% | +30.2% |
| MYL | Sell | MYLAN N V | $25,580,000 | -64.3% | 376,951 | -68.8% | 1.07% | -60.8% |
| ZSPH | Buy | ZS PHARMA INC | $24,405,000 | +164.5% | 465,839 | +112.4% | 1.02% | +190.9% |
| EW | New | EDWARDS LIFESCIENCE | $22,194,000 | – | 155,825 | +100.0% | 0.93% | – |
| CMRX | New | CHIMERIX INC | $21,940,000 | – | 474,900 | +100.0% | 0.92% | – |
| CLVS | Sell | CLOVIS ONCOLOGY | $21,702,000 | +17.3% | 246,952 | -0.9% | 0.90% | +28.9% |
| TEVA | Sell | TEVA PHARMACEUTICALadr | $21,266,000 | -79.4% | 359,832 | -78.3% | 0.89% | -77.4% |
| XLRN | Buy | ACCELERON PHARMA | $20,632,000 | -9.5% | 652,084 | +8.8% | 0.86% | -0.6% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS | $19,400,000 | -10.4% | 712,968 | +0.8% | 0.81% | -1.6% |
| QURE | New | UNIQURE N.V.shares | $17,545,000 | – | 649,800 | +100.0% | 0.73% | – |
| ISRG | Buy | INTUITIVE SURGICAL INC | $17,533,000 | +15.0% | 36,188 | +19.9% | 0.73% | +26.3% |
| IMDZ | Buy | IMMUNE DESIGN CORP | $16,735,000 | +1081.0% | 810,390 | +1107.2% | 0.70% | +1192.6% |
| NXTM | Buy | NXSTAGE MEDICAL | $16,745,000 | +10.5% | 1,172,196 | +33.8% | 0.70% | +21.2% |
| NVS | Buy | NOVARTIS AGsp adr | $16,571,000 | +40.7% | 168,505 | +41.1% | 0.69% | +54.6% |
| HCA | Buy | HCA HLDGS INC | $15,962,000 | +26.9% | 175,945 | +5.2% | 0.67% | +39.3% |
| NVTA | Buy | INVITAE CORP | $13,835,000 | -5.6% | 929,765 | +6.3% | 0.58% | +3.8% |
| RDY | Sell | DR REDDYS LABS LTDadr | $13,704,000 | -74.2% | 247,714 | -73.3% | 0.57% | -71.6% |
| CI | Buy | CIGNA CORP | $13,454,000 | +35.9% | 83,052 | +8.6% | 0.56% | +49.2% |
| HTWR | Buy | HEARTWARE INTL INC | $12,981,000 | -3.8% | 178,574 | +16.1% | 0.54% | +5.5% |
| TGTX | Buy | TG THERAPEUTICS | $12,808,000 | +89.7% | 772,017 | +77.0% | 0.53% | +108.6% |
| NVO | Buy | NOVO-NORDISK ASadr | $11,909,000 | +14.5% | 217,475 | +11.7% | 0.50% | +25.8% |
| SGNT | Sell | SAGENT PHARMACEUTICALS | $11,319,000 | -58.4% | 465,625 | -60.2% | 0.47% | -54.3% |
| UHS | Buy | UNIVERSAL HEALTH SVCclass b | $9,541,000 | +22.9% | 67,146 | +1.8% | 0.40% | +34.9% |
| PRGO | Sell | PERRIGO COshares | $4,950,000 | -88.9% | 26,780 | -90.0% | 0.21% | -87.8% |
| VRX | Buy | VALEANT PHARMA INTL | $4,461,000 | +177.3% | 20,081 | +147.9% | 0.19% | +204.9% |
| MNKKQ | Sell | MALLINCKRODT PLCshares | $4,184,000 | -90.4% | 35,545 | -89.6% | 0.18% | -89.4% |
| ASND | Sell | ASCENDIS PHARMA A Ssp adr | $4,165,000 | -67.2% | 235,560 | -67.8% | 0.17% | -63.9% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS | $2,955,000 | -87.7% | 129,542 | -91.8% | 0.12% | -86.5% |
| AKRXQ | Sell | AKORN INC | $2,943,000 | -86.7% | 67,398 | -85.6% | 0.12% | -85.4% |
| IPXL | Buy | IMPAX LABS INC | $2,338,000 | +25.6% | 50,915 | +28.3% | 0.10% | +38.0% |
| EGRX | Buy | EAGLE PHARMACEUTIC | $2,278,000 | +145.7% | 28,169 | +27.3% | 0.10% | +171.4% |
| HZNP | Buy | HORIZON PHARMAshares | $2,276,000 | +70.2% | 65,501 | +27.2% | 0.10% | +86.3% |
| JAZZ | Buy | JAZZ PHARMA PLC | $2,104,000 | +29.5% | 11,948 | +27.0% | 0.09% | +41.9% |
| MCK | Buy | MCKESSON CORP | $2,016,000 | +27.4% | 8,968 | +28.2% | 0.08% | +40.0% |
| LCI | Buy | LANNET INC | $1,938,000 | +11.6% | 32,596 | +27.2% | 0.08% | +22.7% |
| ENDP | Buy | ENDO INTL PLCshares | $1,893,000 | +12.9% | 23,771 | +27.2% | 0.08% | +23.4% |
| ALKS | Buy | ALKERMES PLCshares | $1,861,000 | +34.1% | 28,923 | +27.0% | 0.08% | +47.2% |
| DEPO | Buy | DEPOMED INC | $1,505,000 | +23.0% | 70,114 | +28.3% | 0.06% | +37.0% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $1,249,000 | +43.6% | 99,852 | +26.2% | 0.05% | +57.6% |
| PCRX | Buy | PACIRA PHARMACEUTICALS | $1,247,000 | +0.7% | 17,632 | +26.5% | 0.05% | +10.6% |
| EARS | Sell | AURIS MED HLDG AG | $1,109,000 | -25.9% | 228,132 | -18.5% | 0.05% | -19.3% |
| ACHN | Sell | ACHILLION PHARMACEUTICALS | $872,000 | -97.2% | 98,400 | -96.9% | 0.04% | -97.0% |
| CBM | Buy | CAMBREX CORP | $648,000 | +40.0% | 14,744 | +26.3% | 0.03% | +50.0% |
| AMPH | Sell | AMPHASTAR PHARMACEUTICALSshares | $640,000 | -94.2% | 36,400 | -95.0% | 0.03% | -93.5% |
| CTLT | Buy | CATALENT INC | $526,000 | +18.2% | 17,922 | +25.4% | 0.02% | +29.4% |
| CHRS | Buy | COHERUS BIOSCIENCES | $462,000 | +19.4% | 15,974 | +26.2% | 0.02% | +26.7% |
| SYK | New | STRYKER CORP | $40,000 | – | 420 | +100.0% | 0.00% | – |
| STJ | New | ST JUDE MEDICAL INC | $22,000 | – | 305 | +100.0% | 0.00% | – |
| ARAY | Sell | ACCURAY INC | $16,000 | -99.2% | 2,395 | -98.9% | 0.00% | -98.8% |
| ZBH | New | ZIMMER BIOMET HLDS | $27,000 | – | 245 | +100.0% | 0.00% | – |
| ENTL | New | ENTELLUS MED INC | $13,000 | – | 505 | +100.0% | 0.00% | – |
| BAX | New | BAXTER INTL INC | $22,000 | – | 315 | +100.0% | 0.00% | – |
| BDX | New | BECTON DICKINSON | $30,000 | – | 210 | +100.0% | 0.00% | – |
| BSX | New | BOSTON SCIENTIFIC | $33,000 | – | 1,870 | +100.0% | 0.00% | – |
| TNDM | Sell | TANDEM DIABETES CARE | $7,000 | -99.5% | 650 | -99.4% | 0.00% | -100.0% |
| SPNC | New | SPECTRANETICS CORP | $5,000 | – | 230 | +100.0% | 0.00% | – |
| THOR | New | THORATEC LABS CORP | $11,000 | – | 250 | +100.0% | 0.00% | – |
| XENT | New | INTERSECT ENT INC | $9,000 | – | 320 | +100.0% | 0.00% | – |
| IART | New | INTEGRA LIFESCIENCE | $6,000 | – | 95 | +100.0% | 0.00% | – |
| VAR | New | VARIAN MED SYS INC | $10,000 | – | 115 | +100.0% | 0.00% | – |
| HOLX | New | HOLOGIC INC | $9,000 | – | 225 | +100.0% | 0.00% | – |
| CSII | New | CARDIOVASCULAR SYS | $8,000 | – | 285 | +100.0% | 0.00% | – |
| TRNX | New | TORNIER N Vshares | $10,000 | – | 395 | +100.0% | 0.00% | – |
| EBIO | Exit | ELEVEN BIOTHERAPEUTICS | $0 | – | -112,485 | -100.0% | -0.04% | – |
| WX | Exit | WUXI PHARMATECH ADSsp adr | $0 | – | -40,653 | -100.0% | -0.06% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -150,654 | -100.0% | -0.08% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -208,889 | -100.0% | -1.02% | – |
| GEVA | Exit | SYNAGEVA BIOPHARMA | $0 | – | -365,684 | -100.0% | -1.35% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS | $0 | – | -3,825,256 | -100.0% | -1.85% | – |
| B108PS | Exit | ACTAVIS PLCshares | $0 | – | -374,407 | -100.0% | -4.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.